Ultra high dose rate Synchrotron Microbeam Radiation Therapy. Preclinical evidence in view of a clinical transfer.

Eling, Laura; Bouchet, Audrey Michele; Nemoz, Christian; Djonov, Valentin; Balosso, Jacques; Laissue, Jean; Bräuer-Krisch, Elke; Adam, Jean Francois; Serduc, Raphael (2019). Ultra high dose rate Synchrotron Microbeam Radiation Therapy. Preclinical evidence in view of a clinical transfer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 139, pp. 56-61. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2019.06.030

[img] Text
1-s2.0-S0167814019329706-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB)

This paper reviews the current state of the art of an emerging form of radiosurgery dedicated to brain tumour treatment and which operates at very high dose rate (kGy·s-1). Microbeam Radiation Therapy uses synchrotron-generated X-rays which triggered normal tissue sparing partially mediated by FLASH effect.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy > Topographical and Clinical Anatomy

UniBE Contributor:

Bouchet, Audrey Michele, Djonov, Valentin Georgiev, Laissue, Jean

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1879-0887

Publisher:

Elsevier Scientific Publ. Ireland

Language:

English

Submitter:

David Christian Haberthür

Date Deposited:

30 Dec 2020 09:17

Last Modified:

05 Dec 2022 15:42

Publisher DOI:

10.1016/j.radonc.2019.06.030

PubMed ID:

31307824

Uncontrolled Keywords:

Brain tumours responses High dose rate Normal tissue sparing Synchrotron Microbeam Radiation Therapy

BORIS DOI:

10.48350/149213

URI:

https://boris.unibe.ch/id/eprint/149213

Actions (login required)

Edit item Edit item
Provide Feedback